Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Discontinuation rates due to adverse effects remain relatively low, with approximately 6% of Zepbound users and 8% of Wegovy users stopping treatment ^2
Abstract Glucagon-like petide-1 (GLP-1) potentiates insulin and suppresses glucagon secretion from the pancreas in response to the ingestion of nutrients
Compounded drug products have not been approved by the FDA, or reviewed by the FDA for safety, effectiveness, or quality
Problem #3 (Probably the Worst?): They Result in Muscle Loss Lets put aside the short-term and long-term side effects that I just mentioned and focus on something more important: The type of weight loss that GLP-1 agonists cause
Frequently asked questions Does BCBS cover Zepbound for weight loss
Key findings: Prescribing trends Using a subset of real-world electronic health record (EHR) data from Truveta, Truveta Research identified people who were prescribed a GLP-1 RA between January 01, 2018 and December 31, 2024
